CIK 0001662774
- Non-accelerated filer
- Smaller reporting company
IRulya Therapeutics Inc.
Sign in to watch- Ticker
- IRLA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 901024039
- Phone
- +1 203-208-8994
- Business address
- 101 COLLEGE STREET, SUITE 210, NEW HAVEN, CT, 06510
- Former names
- Quince Therapeutics, Inc., Cortexyme, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-11 | Lamond David Director | Grant or award · Director Stock Option (Right to Buy) | +2,700 | 2,700 | ||
| 2026-01-02 | Lamond David Director | Grant or award · Director Stock Option (Right to Buy) | +29,423 | 29,423 | ||
| 2025-06-04 | Lamond David Director | Grant or award · Director Stock Option (Right to Buy) | +27,000 | 27,000 | ||
| 2025-01-02 | Lamond David Director | Grant or award · Director Stock Option (right to buy) | +47,587 | 47,587 | ||
| 2024-06-05 | Lamond David Director | Grant or award · Employee Stock Option (right to buy) | +27,000 | 27,000 | ||
| 2023-12-14 | Lamond David Director | Purchase | +22,627 | $1.04 | $24K | 2,347,545 |
| 2023-12-13 | Lamond David Director | Purchase | +22,627 | $1.00 | $23K | 2,324,918 |
| 2023-12-12 | Lamond David Director | Purchase | +300 | $1.00 | $300 | 2,279,964 |
| 2023-12-12 | Lamond David Director | Purchase | +22,327 | $1.02 | $23K | 2,302,291 |
| 2023-12-07 | Lamond David Director | Purchase | +19,123 | $1.01 | $19K | 2,279,664 |
| 2023-12-06 | Lamond David Director | Purchase | +19,123 | $1.02 | $20K | 2,260,541 |
| 2023-12-05 | Lamond David Director | Purchase | +19,123 | $1.01 | $19K | 2,241,418 |
| 2023-12-01 | Lamond David Director | Purchase | +14,378 | $0.94 | $14K | 2,222,295 |
| 2023-11-30 | Lamond David Director | Purchase | +14,378 | $0.90 | $13K | 2,207,917 |
| 2023-11-29 | Lamond David Director | Purchase | +14,378 | $0.98 | $14K | 2,193,539 |
| 2023-08-31 | Lamond David Director | Purchase | +41,026 | $1.32 | $54K | 2,179,161 |
| 2023-08-30 | Lamond David Director | Purchase | +41,026 | $1.31 | $54K | 2,138,135 |
| 2023-08-17 | Lamond David Director | Purchase | +24,766 | $1.29 | $32K | 2,097,109 |
| 2023-08-16 | Lamond David Director | Purchase | +117,348 | $1.29 | $151K | 2,072,343 |
| 2023-08-15 | Lamond David Director | Purchase | +107,886 | $1.32 | $142K | 1,954,995 |
Page 1 of 3 · 49 trades